Truvestments Capital LLC Protalix Bio Therapeutics, Inc. Transaction History
Truvestments Capital LLC
- $363 Million
- Q3 2024
A detailed history of Truvestments Capital LLC transactions in Protalix Bio Therapeutics, Inc. stock. As of the latest transaction made, Truvestments Capital LLC holds 2,458 shares of PLX stock, worth $5,899. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,458Holding current value
$5,899% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding PLX
# of Institutions
51Shares Held
3.6MCall Options Held
61.1KPut Options Held
36.2K-
Jim Simons Renaissance Technologies LLC | New York, Ny956KShares$2.29 Million0.0% of portfolio
-
Gsa Capital Partners LLP London, X0435KShares$1.04 Million0.03% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny374KShares$897,0160.0% of portfolio
-
Black Rock Inc. New York, NY333KShares$799,6100.0% of portfolio
-
Stratos Wealth Partners, Ltd.270KShares$648,0000.0% of portfolio
About Protalix BioTherapeutics, Inc.
- Ticker PLX
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,753,400
- Market Cap $119M
- Description
- Protalix BioTherapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally. The company offers Elelyso fo...